COVID-19: Sovereign Pharma dispatches first batch of generic remdesivir to Cipla Ruchika Sharma8 July 2020 1:15 PM ISTAt current capacity, the Sovereign can supply 50,000 to 95,000 vials per month of the injectable, the company said in an emailed statement on Tuesday.
COVID-19: Mylan to launch Remdesivir at Rs 4800 per vial in India Ruchika Sharma7 July 2020 11:49 AM IST"The drug will be launched under the brand name 'Desrem' in India and will be available to patients in July at a price of Rs 4,800, which is more than...
COVID-19: Govt revises remdesivir dosage, now to be taken for five days Ruchika Sharma5 July 2020 10:45 AM ISTIn the latest protocol, the ministry has informed the dosage of remdesivir should be-- 200 mg IV on day 1 followed by 100 mg IV daily for 4 days (5...
CDSCO shows green flag to Mylan for remdesivir for 'restricted emergency use' Ruchika Sharma3 July 2020 2:22 PM ISTWritten informed consent of each patient is required before the use of the drug while active post-marketing surveillance data and reporting of serious...
Gilead Sciences condemned for pricing coronavirus drug at USD 2340 Ruchika Sharma30 Jun 2020 10:45 AM ISTBut recent news that a cheap steroid called dexamethasone improves survival means remdesivir should be priced between USD 2,520 and USD 2,800, the...
Cipla to knock out Hetero Healthcare in pricing battle of Remdesivir? Farhat Nasim29 Jun 2020 5:13 PM ISTNew Delhi: Igniting drug pricing battle among pharmaceutical majors, Drug major, Cipla Ltd., has priced antiviral drug Remdesivir at under Rs...
South Korea urges caution with dexamethasone, backs remdesivir for Covid-19 Ruchika Sharma27 Jun 2020 9:00 AM ISTNew Delhi: South Korea has added Gilead's anti-viral drug remdesivir to its coronavirus treatment guidelines in its first revision of recommendations...
Hetero Healthcare to supply 20000 vials of antiviral drug Covifor at Rs 5400 per vial across India Ruchika Sharma25 Jun 2020 1:05 PM ISTHetero Healthcare is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which will be immediately supplied to...
COVID Fight: Medical experts caution against Remdesivir, Favipiravir as "no game changer" Ruchika Sharma24 Jun 2020 12:23 PM ISTIt has been found that they help reduce viral load but are not game changers, Maurya said.
Covid-19 Drug: Cipla to price generic version of Remdesivir at less than Rs 5000 Ruchika Sharma24 Jun 2020 11:55 AM ISTHetero expects to price a similar 100 milligram dose of the treatment at 5,000 to 6,000 rupees.
COVID-19: Cipla launches remdesivir under brand name Cipremi in India Ruchika Sharma22 Jun 2020 4:17 PM ISTCipla has been granted regulatory approval by the Drug Controller General of India (DCGI) for restricted emergency use in the country as part of the...
Cipla, Hetero Labs secure DCGI nod for Remdesivir to treat COVID cases Ruchika Sharma22 Jun 2020 11:01 AM ISTThe drug, administered in the form of injection, should be given at a dose of 200 mg on day one followed by 100 mg daily for five days.
